| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 103 | 28.898 | 27.330 | 30.670 | 22.101 | 32.299 | 33.373 |
| Total Income - EUR | - | - | - | 103 | 28.898 | 27.330 | 30.670 | 22.101 | 32.299 | 33.373 |
| Total Expenses - EUR | - | - | - | 309 | 25.006 | 24.006 | 24.736 | 21.331 | 29.449 | 34.548 |
| Gross Profit/Loss - EUR | - | - | - | -206 | 3.892 | 3.324 | 5.934 | 770 | 2.850 | -1.175 |
| Net Profit/Loss - EUR | - | - | - | -209 | 3.025 | 2.566 | 5.032 | 107 | 2.440 | -1.175 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ritmocardio Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 138 | 5.826 | 5.963 | 7.956 | 5.648 | 8.467 | 4.769 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 3.141 | 3.713 | 2.151 | 1.207 | 2.639 | 368 |
| Cash | - | - | - | 138 | 2.685 | 2.250 | 5.805 | 4.441 | 5.828 | 4.401 |
| Shareholders Funds | - | - | - | -166 | 2.862 | 2.415 | 5.080 | 5.203 | 7.627 | 4.399 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 304 | 2.964 | 3.548 | 2.875 | 446 | 840 | 370 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ritmocardio Plus S.r.l.